BioPlus Acquisition Corp.
BIOS · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Market Cap | $6 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $1 | $0 |
| Enterprise Value | $6 | $0 | $2 | $2 |
| Revenue | $0 | $0 | $1 | $1 |
| % Growth | – | -100% | -13.3% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | 34.3% | 33% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | – | – | -12% | -3.1% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -7.3% | -16% |
| EPS Diluted | 0.2 | -0.022 | -0.4 | -1.06 |
| % Growth | 1,000.9% | 94.5% | 62.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |